Paper39189367
PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.
Morone B and 1 other. Expert Rev Mol Med, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology. Papers, record 39189367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39189367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| ADP-Ribosylation | Major topic |
| Signal Transduction | Major topic |
| Interferons | Major topic |
| Poly(ADP-ribose) Polymerases | Major topic |
| Poly(ADP-ribose) Polymerase Inhibitors | Major topic |
| Humans | |
| Animals | |
| DNA Repair |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30988430 | ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP. | Nat Microbiol | 2019 | https://conductscience.org/library/papers/30988430 | PubMed |
| 2 | 37509350 | Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509350 | PubMed |
| 3 | 35637402 | Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35637402 | PubMed |
| 4 | 29515234 | PARP10 suppresses tumor metastasis through regulation of Aurora A activity. | Oncogene | 2018 | https://conductscience.org/library/papers/29515234 | PubMed |
| 5 | 38011562 | PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/38011562 | PubMed |
| 6 | 36358629 | PARP10 Mediates Mono-ADP-Ribosylation of Aurora-A Regulating G2/M Transition of the Cell Cycle. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358629 | PubMed |
| 7 | 34158578 | PARP14 regulates cyclin D1 expression to promote cell-cycle progression. | Oncogene | 2021 | https://conductscience.org/library/papers/34158578 | PubMed |
| 8 | 31892342 | Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis. | Genome Biol | 2019 | https://conductscience.org/library/papers/31892342 | PubMed |
| 9 | 23103912 | PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. | Nat Cell Biol | 2012 | https://conductscience.org/library/papers/23103912 | PubMed |
| 10 | 25382312 | PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript. | Nat Commun | 2014 | https://conductscience.org/library/papers/25382312 | PubMed |
| 11 | 36030235 | The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1. | Nat Commun | 2022 | https://conductscience.org/library/papers/36030235 | PubMed |
| 12 | 33475085 | Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells. | Elife | 2021 | https://conductscience.org/library/papers/33475085 | PubMed |
| 13 | 34969853 | PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/34969853 | PubMed |
| 14 | 27791205 | Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents. | Oncotarget | 2016 | https://conductscience.org/library/papers/27791205 | PubMed |
| 15 | 26934315 | PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/26934315 | PubMed |
| 16 | 37077937 | Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells. | Cancer Res Commun | 2023 | https://conductscience.org/library/papers/37077937 | PubMed |
| 17 | 26699384 | Germline PARP4 mutations in patients with primary thyroid and breast cancers. | Endocr Relat Cancer | 2016 | https://conductscience.org/library/papers/26699384 | PubMed |
| 18 | 30154409 | PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30154409 | PubMed |
| 19 | 30297535 | Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer. | Cancer Res | 2018 | https://conductscience.org/library/papers/30297535 | PubMed |
| 20 | 27874829 | In vivo vizualisation of mono-ADP-ribosylation by dPARP16 upon amino-acid starvation. | Elife | 2016 | https://conductscience.org/library/papers/27874829 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41930181 | Roles of ADP-Ribosyltransferases in Cancer. | Oncol Res | 2026 | https://conductscience.org/library/papers/41930181 | PubMed |
| 41900841 | Interplay Between Poly(ADP-ribosyl)ation and Specific Inner Cellular Events That Suggest Combination Strategies for Overcoming PARP Inhibitor Resistance. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900841 | PubMed |
| 41847180 | Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41847180 | PubMed |
| 41712159 | High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41712159 | PubMed |
| 41432900 | PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signalling. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/41432900 | PubMed |
| 41008918 | PARP3 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008918 | PubMed |
| 40810678 | Identification of a prognostic signature consisting of three macrophage-related genes for glioblastoma based on bulk and single-cell transcriptomes analyses. | Ann Med | 2025 | https://conductscience.org/library/papers/40810678 | PubMed |
| 40741921 | Mono-ADP-ribosylating PARP enzymes in cellular signaling and disease. | J Cell Sci | 2025 | https://conductscience.org/library/papers/40741921 | PubMed |
| 40604091 | Exploring possible hub genes of metabolic syndrome and type 2 diabetes mellitus: a systematic network biology study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40604091 | PubMed |
| 39847113 | PARP12-mediated ADP-ribosylation contributes to breast cancer cell fate by regulating AKT activation and DNA-damage response. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/39847113 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| PARP12 | 64761 | PubTator's text mining | https://conductscience.org/library/genes/64761 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39189367
GET https://conductscience.org/api/papers/v1/39189367/references?page=2